Expert Interview
A look at the potential of Gepotidacin in uncomplicated urinary tract infections and the EAGLE-2 and EAGLE-3 trials of Gepotidacin compared to current standard of care, nitrofurantoin.
Ticker(s): GSKInstitution: Garden City OBGYN
- Board Certified Obstetrician and Gynecologist in practice for over 20 years
- treats over 150 patients with urinary tract infections
- Certified Mohel and a member of NOAM (National Organization of American Mohelim) since 1998
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
